Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > Analyst Recommendation
View:
Post by retiredcf on Apr 12, 2016 6:13am

Analyst Recommendation

First stock in the clip. GLTA

https://www.bnn.ca/Video/player.aspx?vid=847352

MSL-T 2016-04-11 BUY James Telfser
 
In the specialty Pharma space, which has had a lot of troubles. Multiples have contracted quite a bit. Compared to their competitors, they have had a much cleaner balance sheet. Haven’t actually made their big acquisitions yet to load up the balance sheet with debt. They were able to raise about $30 million earlier this year. New management has executed well on the deals and their European jurisdiction. At this level, it is a pretty compelling Buy, but you have to be willing to ride out the volatility from headlines.
 
Login to show your approval   Login to show your disapproval / Be the first to comment
Price:
$1.950
Subject:
CANADIAN
Bias:
OPTIMISTIC
Owned:
Yes
Comment by chuck8 on Apr 12, 2016 1:12pm
Retiredcf, a good video clip and glad she asked the more specific question of "why do you specifically like Merus" and his response was insightful IMO. My only question to myself is that in expecting all general equities to sink lower as the year progresses due to world wide economic uncertainty, with these niche pharmaceuticals be able to weather the storm.
Comment by peter75 on Apr 13, 2016 9:13am
as long as the USA dosent raise rates and their market is muddling along equities will do well The market dosent want the USA doing too well Janet wants to get the USA dollar lower than where it sits Raising the rates would kill their dollar, 
Comment by retiredcf on Apr 13, 2016 1:05pm
There's no question that Yellin will raise rates, the question is how soon and how often? She's trying to walk a tightrope and achieve the "Golidlocks scenario" (ie. not too warm and not too cold). If she raises rates too quickly, the US$ will soar, oil will tumble back towards $30 and the world's economies will be in trouble. If she raises rates too slowly, concerns will be ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities